Resverlogix (RVX) Competitors C$0.06 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider Trades RVX vs. EMH, PMN, DMT, MBX, IBT, HBP, BCT, ACST, AEZS, and LTYShould you be buying Resverlogix stock or one of its competitors? The main competitors of Resverlogix include Emerald Health Therapeutics (EMH), ProMIS Neurosciences (PMN), Small Pharma (DMT), Microbix Biosystems (MBX), IBEX Technologies (IBT), Helix BioPharma (HBP), BriaCell Therapeutics (BCT), Acasti Pharma (ACST), Aeterna Zentaris (AEZS), and Liberty Biopharma (LTY). These companies are all part of the "biotechnology" industry. Resverlogix vs. Emerald Health Therapeutics ProMIS Neurosciences Small Pharma Microbix Biosystems IBEX Technologies Helix BioPharma BriaCell Therapeutics Acasti Pharma Aeterna Zentaris Liberty Biopharma Resverlogix (TSE:RVX) and Emerald Health Therapeutics (CVE:EMH) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, dividends, community ranking, profitability, media sentiment, risk and valuation. Which has preferable valuation & earnings, RVX or EMH? Resverlogix has higher earnings, but lower revenue than Emerald Health Therapeutics. Resverlogix is trading at a lower price-to-earnings ratio than Emerald Health Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioResverlogixN/AN/A-C$10.74M-C$0.05-1.10Emerald Health TherapeuticsC$13.02M4.02-C$142.70M-C$0.70-0.37 Does the media refer more to RVX or EMH? In the previous week, Resverlogix's average media sentiment score of 1.38 beat Emerald Health Therapeutics' score of 0.00 indicating that Resverlogix is being referred to more favorably in the media. Company Overall Sentiment Resverlogix Positive Emerald Health Therapeutics Neutral Does the MarketBeat Community believe in RVX or EMH? Resverlogix received 169 more outperform votes than Emerald Health Therapeutics when rated by MarketBeat users. Likewise, 84.01% of users gave Resverlogix an outperform vote while only 57.09% of users gave Emerald Health Therapeutics an outperform vote. CompanyUnderperformOutperformResverlogixOutperform Votes31084.01% Underperform Votes5915.99%Emerald Health TherapeuticsOutperform Votes14157.09% Underperform Votes10642.91% Is RVX or EMH more profitable? Company Net Margins Return on Equity Return on Assets ResverlogixN/A N/A -34.90% Emerald Health Therapeutics N/A N/A N/A SummaryResverlogix beats Emerald Health Therapeutics on 5 of the 8 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Resverlogix News Delivered to You Automatically Sign up to receive the latest news and ratings for RVX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RVX vs. The Competition Export to ExcelMetricResverlogixBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$15.23MC$158.63MC$5.04BC$6.12BDividend Yield7.02%3.31%5.17%5.32%P/E Ratio-1.10294.26122.4226.04Price / SalesN/A15,933.121,179.291,467.10Price / Cash132.5011.2833.5680.51Price / Book-0.207.224.693.32Net Income-C$10.74M-C$19.40MC$118.98MC$293.36M7 Day PerformanceN/A8.99%-2.45%0.99%1 Month PerformanceN/A10.48%-4.03%-1.42%1 Year PerformanceN/A26.18%29.80%41.84% Resverlogix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RVXResverlogixN/AC$0.06flatN/A-15.4%C$15.23MN/A-1.1019Positive NewsEMHEmerald Health TherapeuticsN/AC$0.26-3.8%N/A+0.0%C$52.28MC$13.02M-0.37161PMNProMIS NeurosciencesN/AN/AN/AN/AC$51.48MC$7,558.00-1.786Gap UpHigh Trading VolumeDMTSmall PharmaN/AC$0.15-6.3%N/A+0.0%C$50.37MC$-1,162.00-2.1413Gap DownHigh Trading VolumeMBXMicrobix BiosystemsN/AC$0.31-3.1%N/A+5.1%C$42.38MC$23.36M7.75N/AGap DownIBTIBEX TechnologiesN/AC$1.44flatN/A+67.4%C$35.29MC$8M9.60N/AHBPHelix BioPharmaN/AC$0.70-1.4%N/A+211.1%C$34.31MN/A-3.509Gap UpHigh Trading VolumeBCTBriaCell TherapeuticsN/AN/AN/A-86.2%C$30.46MN/A-1.7016ACSTAcasti PharmaN/AC$0.58+1.8%N/A+0.0%C$25.87MC$115,000.00-1.0732AEZSAeterna ZentarisN/AN/AN/AN/AC$25.37MC$2.37M-2.6120LTYLiberty BiopharmaN/AC$2.00+∞N/A+0.0%C$21.54MN/A-12.66N/AGap Up Related Companies and Tools Related Companies Emerald Health Therapeutics Competitors ProMIS Neurosciences Competitors Small Pharma Competitors Microbix Biosystems Competitors IBEX Technologies Competitors Helix BioPharma Competitors BriaCell Therapeutics Competitors Acasti Pharma Competitors Aeterna Zentaris Competitors Liberty Biopharma Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:RVX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Resverlogix Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Resverlogix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
